Literature DB >> 2295280

Gastrointestinal malignancies in Crohn's disease. A 20-year experience.

P E Savoca1, G H Ballantyne, C E Cahow.   

Abstract

The relationship between gastrointestinal neoplasms and Crohn's disease is poorly defined. The purpose of this study was to characterize the features of gastrointestinal malignancies that developed in Crohn's patients. In this retrospective review the authors identified six patients with Crohn's disease who developed such lesions over a 20-year period: four patients had colorectal cancers and two had ileal malignant neoplasms. Patients averaged 52.7 years of age (range, 21 to 61 years). Three patients were men and three women. Five of the six patients had endured Crohn's disease for more than 20 years. Only two lesions were diagnosed before surgery. The colorectal lesions were predominantly right-sided and all occurred in bowel segments with active Crohn's disease. The lesions demonstrated aggressive histologic features: three of six tumors were poorly differentiated, one of the five adenocarcinomas was mucinous, and three of the colorectal cancers were Dukes' B or C lesions. Four of six patients survived five or more years. There was a single malignant carcinoid, which represents the seventh case report of a carcinoid tumor occurring in a patient with Crohn's disease. This study indicates that patients with Crohn's disease develop a wide variety of small bowel and colorectal cancers. Furthermore, it suggests that Crohn's patients with colonic disease should periodically undergo surveillance colonoscopy.

Entities:  

Mesh:

Year:  1990        PMID: 2295280     DOI: 10.1007/bf02053192

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  12 in total

1.  Synchronous ileal and colonic adenocarcinomas associated with Crohn's disease: report of a case with a focus on genetic alterations and carcinogenesis.

Authors:  B Baisse; C Fontolliet; Y S Bian; H Vuilleumier; J Benhattar
Journal:  J Clin Pathol       Date:  2004-08       Impact factor: 3.411

2.  Mixed adenocarcinoma/carcinoid tumour of large bowel in a patient with Crohn's disease.

Authors:  Y L Hock; K W Scott; R H Grace
Journal:  J Clin Pathol       Date:  1993-02       Impact factor: 3.411

3.  Cancer in Crohn's disease: dispelling the myths.

Authors:  D B Sachar
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

4.  Studies on peroxisomes of colonic mucosa in Crohn's disease.

Authors:  I Aimone-Gastin; S Cable; J M Keller; M A Bigard; B Champigneulle; P Gaucher; J L Gueant; M Dauça
Journal:  Dig Dis Sci       Date:  1994-10       Impact factor: 3.199

5.  Microsatellite instability is uncommon in intestinal mucosa of patients with Crohn's disease.

Authors:  A Noffsinger; S Kretschmer; J Belli; F Fogt; C Fenoglio-Preiser
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

6.  Intestinal cancer in patients with Crohn's disease.

Authors:  Sabine Kersting; Matthias Bruewer; Mike G Laukoetter; Emile M Rijcken; Rudolf Mennigen; Horst Buerger; Norbert Senninger; Christian F Krieglstein
Journal:  Int J Colorectal Dis       Date:  2006-07-18       Impact factor: 2.571

7.  Colorectal adenocarcinoma in Crohn's disease.

Authors:  M B Ribeiro; A J Greenstein; D B Sachar; J Barth; S Balasubramanian; N Harpaz; T M Heimann; A H Aufses
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

8.  Risk factors for small bowel cancer in Crohn's disease.

Authors:  B A Lashner
Journal:  Dig Dis Sci       Date:  1992-08       Impact factor: 3.199

Review 9.  Small bowel adenocarcinoma and Crohn's disease: any further ahead than 50 years ago?

Authors:  Caitlin Cahill; Philip H Gordon; Andrea Petrucci; Marylise Boutros
Journal:  World J Gastroenterol       Date:  2014-09-07       Impact factor: 5.742

10.  Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention.

Authors:  P M Choi; M P Zelig
Journal:  Gut       Date:  1994-07       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.